In 2018, the National Institute on Aging and Alzheimer’s Association (NIA-AA) proposed criteria to define AD by its underlying pathophysiological processes known as the A/T/N framework, i.e., amyloid, tau, and neurodegeneration [11]. Here, MAPT is linked to Alzheimer disease.